BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 24641153)

  • 1. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010.
    Reekie JM; Levy MH; Richards AH; Wake CJ; Siddall DA; Beasley HM; Kumar S; Butler TG
    Med J Aust; 2014 Mar; 200(5):277-80. PubMed ID: 24641153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
    Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
    Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spread of bloodborne viruses among Australian prison entrants.
    Crofts N; Stewart T; Hearne P; Ping XY; Breshkin AM; Locarnini SA
    BMJ; 1995 Feb; 310(6975):285-8. PubMed ID: 7866168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey.
    Long J; Allwright S; Barry J; Reynolds SR; Thornton L; Bradley F; Parry JV
    BMJ; 2001 Nov; 323(7323):1209-13. PubMed ID: 11719410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
    Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
    Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in hepatitis B prevalence and associated risk factors among Indigenous and non-Indigenous prison entrants in Australia, 2004 to 2013.
    Coles T; Simpson P; Saulo D; Kaldor J; Richards A; Levy M; Wake C; Siddall DA; Harrod ME; Kariminia A; Butler T
    Aust N Z J Public Health; 2019 Jun; 43(3):236-240. PubMed ID: 30690821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States.
    Hennessey KA; Kim AA; Griffin V; Collins NT; Weinbaum CM; Sabin K
    J Urban Health; 2009 Jan; 86(1):93-105. PubMed ID: 18622707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bloodborne virus infections among drug users in Ireland: a retrospective cross-sectional survey of screening, prevalence, incidence and hepatitis B immunisation uptake.
    Grogan L; Tiernan M; Geogeghan N; Smyth B; Keenan E
    Ir J Med Sci; 2005; 174(2):14-20. PubMed ID: 16094907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of the viral hepatitis B and C in female prisoners of Metropolitan Regional Prison Complex in the State of Goiás, Central Brazil.
    Barros LA; Pessoni GC; Teles SA; Souza SM; Matos MA; Martins RM; Del-Rios NH; Matos MA; Carneiro MA
    Rev Soc Bras Med Trop; 2013; 46(1):24-9. PubMed ID: 23563821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County.
    Gahrton C; Westman G; Lindahl K; Öhrn F; Dalgard O; Lidman C; Nilsson LH; Said K; Duberg AS; Aleman S
    BMC Infect Dis; 2019 Nov; 19(1):955. PubMed ID: 31706284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey.
    Wali A; Khan D; Safdar N; Shawani Z; Fatima R; Yaqoob A; Qadir A; Ahmed S; Rashid H; Ahmed B; Khan S
    BMC Public Health; 2019 Dec; 19(1):1631. PubMed ID: 31801496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.
    Allwright S; Bradley F; Long J; Barry J; Thornton L; Parry JV
    BMJ; 2000 Jul; 321(7253):78-82. PubMed ID: 10884256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
    Removille N; Origer A; Couffignal S; Vaillant M; Schmit JC; Lair ML
    BMC Public Health; 2011 May; 11():351. PubMed ID: 21595969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
    Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
    J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England.
    Edeh J; Spalding P
    J Public Health Med; 2000 Dec; 22(4):531-9. PubMed ID: 11192282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV prevalence at reception into Australian prisons, 1991-1997.
    McDonald AM; Ryan JW; Brown PR; Manners CJ; Falconer AD; Kinnear RC; Harvey WJ; Hearne PR; Banaszczyk M; Kaldor JM
    Med J Aust; 1999 Jul; 171(1):18-21. PubMed ID: 10451666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and Hepatitis C in prisons: a prevalence study.
    Kose S; Adar P; Gozaydin A; Kuzucu L; Akkoclu G
    Int J Prison Health; 2019 Jun; 15(2):162-167. PubMed ID: 31172859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B and C in New South Wales prisons: prevalence and risk factors.
    Butler TG; Dolan KA; Ferson MJ; McGuinness LM; Brown PR; Robertson PW
    Med J Aust; 1997 Feb; 166(3):127-30. PubMed ID: 9059433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.